Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:57 AM
Ignite Modification Date:
2025-12-25 @ 4:57 AM
NCT ID:
NCT01900418
Eligibility Criteria:
Inclusion Criteria:
* Taking an aromatase inhibitor as adjuvant treatment for State I, II, or II breast cancer for at least 4 weeks
* Experiencing more than mild joint pain/symptoms
* 21 or older
* have permission from physician to engage in moderate intensity physical activity
Exclusion Criteria:
* Undergoing chemotherapy and/or radiation therapy at any time during the study period
* Scheduled for major surgery during the study period
* Presently engaged in high levels of physical activity on a daily basis
* Less than 21 years of age
* Unable to walk or engage in moderate intensity physical activity
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
21 Years
Maximum Age:
99 Years
Study:
NCT01900418
Study Brief:
Protocol Section:
NCT01900418